For Patients Colon Cancer
Cancer - many diseases under one term.

Colon Cancer

In colon cancer, a distinction is made between hereditary and sporadic forms.  
If a hereditary form is suspected (approx. 10% of cases), we recommend a visit to a genetic consultation for further diagnostic planning.

Colon cancer accounts for approximately 14% of all tumors in adults. In the case of somatic (non-hereditary) forms of this type of tumor, a molecular pathological laboratory examination from a tissue sample of the tumor is necessary before starting therapy. For this purpose, please discuss the individual procedure with your attending physician.

More Information

Patients with a mutation in the genetic material of the tumor (e.g. in the KRAS gene) respond less well to certain forms of therapy than patients without a mutation. This analysis (of the genes BRAF, KRAS, NRAS and the so-called MSI, among others) on tumor tissue can be requested by your treating physician and easily be performed by us.
After therapy, a special laboratory test called "Liquid Biopsy" can be used to check whether the tumor has been completely removed or, in the rare case that this has not been successful, whether new tumor cells are developing. Liquid Biopsy detects this at an early stage. For this purpose, a blood sample is taken at regular intervals and examined for genetic material originating from the tumor.